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ABSTRACT 
The health benefits of a high fiber diet have been known since the 1 9th century with 
many different forms of studies conducted to show its advantages. Though not all of the 
pathophysiological benefits are understood about diets including high fiber whole grains 
and high fiber breads, many studies in recent years show strong evidence of significant 
inverse relationships with body mass index, total cholesterol, low density lipoprotein, and 
fasting insulin levels. 
The purposes of this study were to 1) determine the effects of increasing the 
consumption of breads containing high fiber on an overweight population's diet, 2) 
evaluate if the health risks associated with heart disease would decrease, 3) determine if 
increased fiber consumption affected liver function and to evaluate food frequency 
consumption of various foods over the study period. 
A total of 21 female participants completed the study with nine in the control group 
and 12 in the experimental group. Participants were randomly assigned to either a 
control group receiving information on the benefits of a high fiber diet or into an 
experimental group receiving information on the benefits of a high fiber diet and breads 
high in fiber. The experimental group picked up bread bimonthly and was instructed to 
gradually increase their consumption. Participants were instructed to consume three 
slices of bread per day for the first two weeks, gradually increasing up to six slices of 
bread per day for the final two weeks by increasing their consumption one slice per day 
every two weeks over the course of the eight week study. At four and eight weeks both 
the control group and experimental group were asked to return for follow-up and to 
complete a food frequency questionnaire. 
One, four, and eight week body weight, body composition, body mass index, blood 
glucose, lipid profile, liver enzyme function tests and food frequency data were analyzed 
using SPSS statistical software. Means, standard deviations and two way analysis of 
variance with repeated measures on week 1, week 4, and week 8, using "CON EXPO" 
were determined. 
Results indicated that there were no significant differences found within each group 
or between groups in any comparison as result of increased high fiber whole grain bread 
comsumption. However, the findings did show an association between decreased mean 
cholestrol, triglycerides and low density lipoprotein values in participants given an 
informational handout illustrating the nutritional benefits of eating a high fiber diet. 
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Chapter I: Introduction 
Diet and nutrition are important factors in the promotion and maintenance of good 
health throughout the entire life span. Their role as determinants of chronic health risk 
and life span is well established and therefore occupy a prominent position in prevention 
activities. 
The burden of chronic diseases is rapidly increasing worldwide. It has been 
calculated that in 2001, chronic diseases contributed approximately 60% of the 56.5 
million total reported deaths in the world and approximately 46% of the global burden of 
disease (World Health Organization [WHO], 2003). The proportion of the burden of 
cardiovascular diseases is expected to increase to 57% by 2020. Almost half of the total 
chronic disease deaths are attributable to cardiovascular diseases. Obesity and diabetes 
are also showing worrying trends, not only because these conditions affect a large 
proportion of the population, but also because they have started to appear earlier in life. 
Many chronic diseases are largely preventable. Although more basic research may 
be needed on some aspects of the mechanisms that link diet to health, the currently 
available scientific evidence provides a sufficiently strong and plausible basis to justify 
taking action now and using nutrition as a preventative method to fight many chronic 
diseases. 
According to the American Dietetic Association (2005), the Dietary Guidelines 
for Americans provide science-based advice to promote health and to reduce risk for 
major chronic diseases through diet and physical activity. Major causes of morbidity and 
mortality in the United States are related to poor diet and a sedentary lifestyle. Some 
specific diseases linked to poor diet and physical inactivity include; cardiovascular 
disease, type 2 diabetes, hypertension, osteoporosis, and certain cancers. Furthermore, 
poor diet and physical inactivity resulting in an energy imbalance (more calories 
consumed than expended) are the most important factors contributing to the increase in 
overweight and obesity in this country. Coupled with physical activity, following a diet 
that does not provide excess calories according to the recommendations should enhance 
the health of most individuals. 
The Dietary Guidelines encourage the consumption of three or more ounce- 
equivalents of whole-grain products per day, with the remainder of the recommended 
grain sources from enriched or whole-grain products. In general, at least half of the 
grains in a daily diet should come from whole grains. 
Statement of the Problem 
The purpose of this study was to determine the effects of increasing the 
consumption of breads containing high fiber on an overweight population's diet and to 
evaluate if the health risks associated with heart disease would decrease. A secondary 
purpose was to evaluate if participants' food frequency consumptions of less nutritious 
foods would change. 
Research Objectives 
1. To determine if overweight individuals who receive information on the benefits of 
high fiber diets and gradually increase their consumption of bread containing high 
fiber to six slices per day differ from overweight individuals who receive 
information on the benefits of high fiber diets after a period of 8 weeks. 
2. To determine if the consumption of bread containing high fiber by overweight 
individuals decreased risk factors specifically associated with heart disease. 
3. To determine if the increased consumption of high fiber breads changes the 
frequency of less nutritious foods consumed and reported by overweight 
individuals. 
4. To determine if the increased consumption of high fiber bread would have a 
detrimental impact on liver function. 
Assumptions of the Study 
There are two assumptions apparent in this research. The first is that subjects will 
be consistent in the consumption of the requested gradual increase of high fiber bread 
from three slices per day during the initial 2 weeks of their experiment up to six slices of 
bread per day during the final 2 weeks. Second, when completing their food frequency 
questionnaires it is assumed that the participants will answer in the most accurate way 
possible. 
Definition of Terms 
American Dietetics Association. The American Dietetic Association is the nation's 
largest organization of food and nutrition professionals. 
Appetite. The integrated response to the sight, smell, thought, or taste of food that 
initiates or delays eating. 
Balance (dietary). Providing foods in proportion to each other and in proportion 
to the body's needs. 
Basal metabolic rate (BMR). The rate of energy use for metabolism under 
specified conditions: after a 12 hour fast and restful sleep, without any physical 
activity or emotional excitement, and in a comfortable setting. 
Basal metabolism. The energy needed to maintain life when a body is at complete 
digestive, physical, and emotional rest. 
Blood lipidprofile. Results of a blood test that reveal a persons total cholesterol, 
triglycerides, and various lipoproteins. 
Body composition. The proportions of muscle, bone, fat, and other tissue that 
make up a person's total body weight. 
Body mass index (BMI). An index of a person's weight in relation to height; 
determined by dividing the weight (in kilograms) by the square of the height (in 
meters). This measure has the least correlation with body height and the highest 
correlation with independent measures of body fatness for adults. 
Calories. Units by which energy is measured. One calorie is the amount of heat 
necessary to raise the temperature of 1 kilogram of water 1 degree Celsius. 
Chylomicrons. Are large lipoprotein particles that are created by the absorptive 
cells of the small intestine and transport exogenous lipids to adipose, cardiac, and 
skeletal tissues. 
Constipation. The condition of having infrequent or difficult bowel movements 
objectively assessed by (1) fewer than three stools per week are passed while a 
person in eating a high -residual diet; (2) more than three days go by without the 
passage of a stool; or (3) the weight of stool passed in one day totals less than 35 
grams. 
Diabetes Mellitus. A disorder of carbohydrate metabolism characterized by 
altered glucose regulation and utilization, usually resulting from insufficient 
amount or ineffective insulin usage. 
Dietary reference intakes (DRO. A set of nutrient intake values for healthy people 
in the United States and Canada set forth by the Food and Nutrition Board 
Digestion. The process in which food is broken down into absorbable units by the 
body. 
Fibers. In plant foods, the nonstarch polysaccharides that are not digested by 
human digestive enzymes, although some are digested by the gastrointestinal (GI) 
tract bacteria. Fibers include: cellulose, hemicelluloses, pectins, gums, and 
mucilages, and the nonpolysaccharides lignins, cutins, and tannins. 
Foodfrequency questionnaire. A frequency record of foods most commonly eaten 
by a person over a given period of time such as day, week, or month. 
Glucose. A monosaccharide, also commonly referred to as blood sugar 
High density lipoprotein (HDL). The type of lipoprotein that transports 
cholesterol from the blood stream to the liver from the cells; composed primarily 
of protein. 
Highjber. Five grams or more fiber per serving. A high fiber claim made on 
food that contains more than three grams of fat per serving and per 100 grams of 
food must declare total fat. 
Insolublejber. Indigestible fibrous food components that do not dissolve in 
water. 
Low density lipoprotein (LDL). The type of lipoprotein derived from very-low- 
density lipoproteins (VLDL) as VLDL triglycerides are removed and broken 
down; composed primarily of cholesterol. 
Nutrients. Chemical substances obtained from food and used in the body to 
provide energy, structural materials, and regulating agents to support growth, 
maintenance, and repair of the body's tissues. Nutrients may also reduce the risk 
of some diseases. 
Overweight. Body weight above some acceptable weight that is usually defined 
in relation to height (such as BMI) that places individuals at an increased risk for 
some comorbidities. 
Refined. The process by which the coarse parts of a food are removed. 
Satiating. Having the power to suppress hunger and inhibit eating. 
Satiation. The feeling of satisfaction and fullness that occurs during a meal and 
halts eating. Satiation usually determines how much food is consumed during a 
meal. 
Satiety. The feeling of fullness and satisfaction that occurs after a meal and 
inhibits eating until the next meal. Satiety determines the amount of time that 
passes between meals. 
Stools. Waste matter discharged from the colon; also called feces. 
Limitations of the Study 
The limitations of this study are that the subjects may not consume the 
appropriate amounts of bread in the given time frames and answer honestly and 
accurately on the food frequency questionnaire. 
Chapter 11: Literature Review 
Introduction 
This chapter is divided into three major sections. The first will elaborate on the 
prevalence and effects of overweight and obesity. The second concentrates on the 
diagnostic and screening criteria used in this study. The final section discusses the 
impact of the dietary modification of increased fiber and breads on health. 
Weight Imbalance: Overweight and Obesity 
Overweight is defined as a state in which weight exceeds a standard based on 
height (Mahan & Escott-Stump, 2000). Obesity is characterized by an excess 
accumulation of fat either generalized or localized and is a determinant of health and well 
being (Shils, Olson, Shike, & Ross, 1999). Overweight and obesity are present in males 
and females, all races and ethnicities, and all age groups. Disparities do exist, however, 
and the prevalence of overweight and obesity is higher in women who are of members of 
racial and ethnic minorities compared with non-Hispanic white women. Gender 
differences are also evident. Mexican American and non-Hispanic black women have a 
higher prevalence of overweight and obesity compared with men of the same race. This 
picture reverses in non-Hispanic white men and women, with men having a higher 
prevalence of overweight and obesity then women (Mahan & Escott-Stump, 2004). Over 
half of the adults in the United States are now considered overweight or obese with the 
prevalence especially high among women, the poor, blacks, and Hispanics (Whitney & 
Rolfes, 2005). 
Obesity has reached epidemic proportions globally, with more than 1 billion 
adults overweight - at least 300 million of them clinically obese - and is a major 
contributor to the global burden of chronic disease and disability (World Health 
Organization, 2003). Being overweight or obese can occur only in the face of a positive 
energy balance, so in this case, it is a nutritional disease. Obesity results from a failure of 
the homeostatic mechanisms that balance energy intake and outgo in normal people 
(Shils et al., 1999). 
Overweight and obesity have been directly linked with mortality and many 
chronic aliments including cardiovascular disease, elevated triglyceride levels, increased 
cholesterol, diabetes, hypertension, respiratory problems, gallbladder disease, arthritis 
and cancer (Shils et al., 1999). 
The previously described health effects of obesity impose a significant economic 
cost. These costs have been estimated for numerous developed countries including the 
United States. Obesity leads to a national economic burden estimated at $93 billion per 
year (American Dietetic Association, 2005). Individuals who are also obese have health- 
care costs that are an average of 37% higher then non-obese people. These estimated 
costs are conservative because they reflect only the costs of diagnosing and treating 
illnesses caused by obesity. Other relevant costs include direct costs related to the 
treatment of obesity, indirect costs related to the loss of productivity caused by morbidity 
and premature death, and intangible costs related to reductions in the individual's quality 
of life. 
Ultimately, any intervention to facilitate weight loss or prevent weight gain must 
result in an appropriate relation between energy expenditure and energy intake within the 
individual: to facilitate weight loss, energy expenditure must exceed energy intake 
(National Institute of Health, 1998). Among obese adults, weight loss is advocated 
primarily because of its anticipated and demonstrated positive effects on risk factors for 
diabetes and cardiovascular diseases including lowered blood pressure in hypertensive or 
non-hypertensive individuals. 
Body mass index. BMI is a tool for indicating weight status in adults. The BMI 
describes relative weight for height: BMI = weight (kilograms (kg)) / height (meters 
squared (m2)) (Whitney & Rolfes, 2005). A BMI of 18.5 - 24.9 for adults represents a 
healthy target either for overweight people to achieve or for others to not exceed (Center 
for Disease Control, 2004a). A BMI from 25.0 - 29.9 classifies individuals as 
overweight and a BMI over 30 classifies individuals as obese. 
BMI is only one of many factors used to predict risk for disease. BMI cannot be 
used to tell a person if helshe has a disease such as diabetes or cancer (Center for Disease 
Control, 2004a). However, mortality increases as excess weight increases. People with a 
BMI greater than a value of 35 are twice more likely to die prematurely than people with 
a BMI less that 25. The risks associated with increased BMI appear to also be greater for 
Caucasians than for African Americans (Whitney & Rolfes, 2005). 
The advantage of using BMI as an indicator is that weight and height are easily 
measured by relatively untrained individuals and with easily obtainable and accurate 
equipment. Another advantage is that internationally accepted definitions of BMI can be 
used to assess obesity across studies globally and for subgroups of a population (Center 
for Disease Control, 2004a). However, BMI can be misrepresentative if an individual has 
a overly large body frame or is overly muscular. 
Type 11 diabetes mellitus. Type I1 diabetes mellitus is the most common form of 
diabetes mellitus. In type I1 diabetes mellitus, either the body does not produce enough 
insulin or cells cannot take up the insulin. Insulin is necessary for the body to be able to 
use glucose in the cell and inappropriate levels can result in disorders such as heart 
disease, stroke, kidney disease, eye complications, neuropathy, nerve damage, 
circulation, skin complications, gastroparesis, and diabetes mellitus, and depression 
(American Diabetes Association, 2005). 
An estimated 30 million people worldwide had diabetes mellitus in 1985 (World 
Health Organization, 2005a). A decade later, the global burden of diabetes mellitus was 
estimated to be 135 million. The latest World Health Organization estimate - for the 
number of people with diabetes mellitus, worldwide, in 2000 - was 17 1 million. This is 
likely to increase to at least 366 million by 2030. Two major concerns are that much of 
this increase in diabetes mellitus will occur in developing countries, due to population 
growth, aging, unhealthy diets, obesity and sedentary lifestyles. There is also a growing 
incidence of type I1 diabetes mellitus - which accounts for about 90% of all cases - at a 
younger age. In developed countries most people with diabetes are retired in contrast to 
in developing countries where those individuals most frequently affected are in the 
middle, productive years of their lives, aged between 35 and 64. The number of deaths 
attributed annually to diabetes is around 3.2 million. Diabetes mellitus has become one of 
the major causes of premature illness and death in most countries, mainly through the 
increased risk of cardiovascular disease. 
Because of its chronic nature, the severity of its complications, and the means 
required to control them, diabetes is a costly disease, not only for affected individuals and 
their families, but also for the health care systems and society. Studies in India estimate 
that, for a low-income Indian family with an adult with diabetes, as much as 25% of 
family income may be devoted to diabetes care (World Health Organization, 2005a). For 
families in the USA with a child who has diabetes, the corresponding figure is 10% of 
family income. 
Diabetes mellitus affects approximately 16 million people in the United States 
and accounts for about one sixth of all expenditures for health care (American Family 
Physician, 1999). Ninety percent of patients with diabetes have type I1 diabetes mellitus 
and often require oral agents or insulin for glucose control. The mortality rate in patients 
with diabetes may be up to 11 times higher than in persons without the disease. Diabetes 
mellitus is a leading cause of blindness, renal failure, and foot and leg amputations in 
adults. Managed care and budgeted resources challenge clinicians to provide 
comprehensive health care to patients with diabetes mellitus. 
Diagnostic and Screening Criteria 
Fasting blood glucose. As reported by the College of American Pathologists 
(2005) in 1997, the Expert Committee on the Diagnosis and Classification of Diabetes 
was convened to reexamine the classification and diagnostic criteria for diabetes based on 
the 1979 publication of the National Diabetes Data Group. As a result of its deliberations, 
the expert committee recommended several changes to the diagnostic criteria for diabetes 
and for lesser degrees of impaired glucose regulation. The use of a fasting plasma 
glucose, or FPG, test for the diagnosis of diabetes was recommended, and the cut point 
separating diabetes from nondiabetes was lowered from a FPG > 140 mgldl to > 126 
mgldl (College of American Pathologists, 2005). This change was based on data that 
showed an increase in prevalence and incidence of diabetic retinopathy beginning 
approximately at a FPG of 126 mgldl, as well as on the desire to reduce the discrepancy 
that existed in the number of cases detected by the FPG of > 140 mg/dl and the 2-h value 
in the OGTT (2-h plasma glucose) of > 200 mg/dl. 
In November 2003, the Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus recommended that the criteria to diagnose diabetes remain as 
previously defined (College of American Pathologists, 2005). However, the lower cut 
point defining impaired fasting glucose, or IFG, was reduced from > 110 mgldl to > 100 
mg/dl. Thus, "normal" would now be defined as a FPG of < 100 mgldl. These diagnostic 
criteria for diabetes mellitus were restated in January 2005. 
Lipidpanel. When individuals are overweight, obese, or have diabetes mellitus, 
their risk of heart attack or stroke is increased because of the damage the disease can 
inflict on blood vessels. Unhealthy levels of cholesterol and triglycerides increase the risk 
even farther. 
A lipid panel test helps determine the risk for these kinds of cardiovascular 
problems by measuring the levels of cholesterol and triglycerides in circulating blood. A 
lipid panel - also called a lipid profile - usually includes four measurements of the 
types of fats (lipids) in blood: total cholesterol, total triglycerides, low-density lipoprotein 
(LDL), and high-density lipoprotein (HDL). Each measurement will be discussed in 
more detail. 
Though cholesterol increases with age, a desirable lipoprotein value of cholesterol 
level is less than 200 mgldl for all age ranges and times (Mahan & Escott-Stump, 2000). 
A total cholesterol measurement captures cholesterol contained in all lipoprotein 
fractions: 60%-70% is carried on LDL, 20%-30% on HDL, and 10%-15% on VLDL. 
There is a direct, positive relationship between total serum cholesterol and CHD. 
Populations that consume diets high in saturated fatty acids have increased blood 
cholesterol levels and CHD incidence and mortality. The Third Report of the Expert 
Panel on Detection, Evaluation, and Treatment on High Blood Cholesterol in Adults 
reaffirms that "lowering total cholesterol and LDL reduces CHD risk. A 10% reduction 
in total cholesterol has been shown to decrease CHD incidence by 30% (Center for 
Disease Control, 2004b). 
Triglycerides help the body store fat and are usually found in fat tissue, with only 
low levels normally present in blood. The triglyceride-rich lipoproteins include 
chylomicrons, VLDL, and any remnants or intermediary products formed in catabolism. 
Triglyceride levels are classified as normal (<l50 mgldl), borderline high (1 50-1 99 
mgldl), high (200 - 499 mgldl) and very high (>500 mgldl) (Mahan, 2000). 
LDL is the primary cholesterol carrier in blood; consequently total cholesterol 
levels and LDL cholesterol levels are highly correlated. A desirable LDL level is less 
then 130 mgldl (Mahan & Escott-Stump, 2000). LDL is sometimes called the "bad" 
cholesterol because too much of it in the blood causes the accumulation of fatty deposits 
(plaques) in the arteries (atherosclerosis), reducing blood flow and leading to heart 
disease. In addition, in people with diabetes, LDL cholesterol molecules tend to be 
smaller and denser than in people without diabetes, causing further damage to blood 
vessels. 
HDL is sometimes called the "good" cholesterol because it helps carry LDL 
cholesterol for disposal, keeping arteries clear and blood circulating freely. HDL 
particles contain more protein than any of the other lipoproteins, which accounts for their 
theoretical metabolic role as a reservoir of the apolipoproteins that direct lipid 
metabolism (Mahan & Escott-Stump , 2000). Apo A-1, the main apolipoprotein in HDL, 
is involved in tissue cholesterol removal. High HDL levels are therefore associated with 
low levels of chylomicrons, VLDL, and small, dense LDL. Desirable HDL cholesterol is 
greater than 40 mgldl for men. Because women have higher HDL cholesterol than men, 
and HDL cholesterol levels of greater than 45 mgldl is recommended in women. 
Although these lipids are necessary for the body to function normally, the kind 
and amount present in blood are correlated with an increased risk of heart disease. 
Together, the four laboratory values can provide clues about the risk of having a heart 
attack, stroke, or other blood vessel damage (Mayo Clinic, 2004a). 
Cross-population, within population, and clinical studies have consistently shown 
that a high serum cholesterol level is correlated with increased coronary heart disease and 
mortality (Mayo Clinic, 2004a). In the past 30 years, the carriers of blood lipids and their 
carrier proteins, lipoproteins, have come to the forefront as predictors of risks. 
Each class of lipoproteins actually represents a continuum of particles. The ratio 
of protein to fat determines the density; thus, particles with more protein are denser. The 
physiologic role of lipoproteins includes transporting lipids to cells for energy or storage 
and serving as a substrate for prostaglandins, tromboxanes, and leukotrienes (Mayo 
Clinic, 2004a). Because of different metabolic roles, the lipoproteins also vary in extent 
of atherogenicity. 
A standard lipoprotein profile includes measurement of total cholesterol, LDL 
cholesterol, HDL cholesterol, and triglyceride levels after a 12 hour fast. Most clinical 
laboratories cannot quantify LDL cholesterol directly; the Friedewald formula (LDL = 
(TC) - (HDL) - (TG/5) is used for the calculation. Consequently, a lipid profile must be 
taken in the fasting state (8-12 hours after eating) to allow time for chylomicrons to clear. 
Results of a lipid panel are listed as a set of numbers in milligrams per deciliter 
(mgldl). The results are categorized as optimal, near optimal, borderline high risk, high 
risk and very high risk (Mayo Clinic, 2004a). 
Liver function test. Liver function tests generally refer to blood tests that evaluate 
the presence of liver disease and determine the extent of the disease. These tests include 
liver enzymes, which are markers for liver cell or biliary duct injury as well as markers of 
the ability of the liver to make proteins (Mayo Clinic, 2004b). 
A liver panel is used to detect liver damage or disease. It usually includes six 
tests that are run at the same time on one blood sample including: alanine 
aminotransferase, alkaline phosphatase, aspartate aminotransferase, bilirubin profile, 
albumin, and total protein. 
One or more of these tests are ordered when symptoms suspicious of a liver 
condition are noticed. These include: jaundice, dark urine, or light-colored bowel 
movements; nausea, vomiting and/or diarrhea; loss of appetite; vomiting of blood; bloody 
or black bowel movements; swelling or pain in the belly; unusual weight change; or 
fatigue or loss of stamina (labtestsonline.org, 2006). One or more of these tests may also 
be ordered when a person has been or may have been exposed to a hepatitis virus; has a 
family history of liver disease; has excessive alcohol intake; or is taking a drug that can 
cause liver damage. 
Alanine aminotransferase (ALT) is used to determine if a patient has liver 
damage. ALT is an enzyme involved in the metabolism of the amino acid alanine (NIH, 
2005). ALT is in a number of tissues but it is in highest concentrations in the liver. Injury 
to the liver results in release of the enzyme into the blood. Normal range can vary 
according to a number of factors, including age and gender with the normal value from 7- 
56 IUIL (international units per liter). 
Alkaline phosphatase (ALKP) is an enzyme in the blood, intestines, liver, and 
bone cells. Its chemical structure varies (called isoenzymes) depending on where it is 
produced (National Institute of Health, 2005). This test makes it possible to determine 
where a problem has originated. When bones are growing, liver cells are damaged, or a 
biliary obstruction occurs, alkaline phosphatase levels rise considerably. The normal 
value is 20 to 140 IUIL with the test about 80% accurate for identifying specific locations 
of cancers or disease. 
Aspartate aminotransferase (AST) is in high concentration in heart muscle, liver 
cells, skeletal muscle cells, and to a lesser degree, in other tissues (National Institute on 
Health, 2005). Although elevated serum AST is not specific for liver disease, it is used 
primarily to diagnose and monitor the course of liver disease (in combination with other 
enzymes such as ALT, ALKP, and bilirubin. The normal range is 10 to 34 IUIL. 
Bilirubin is a breakdown product of hemoglobin (National Institute of Health, 
2005). Total and direct bilirubin are usually measured to screen for or to monitor liver or 
gall bladder dysfunction. This test is usehl in determining if a patient has liver disease 
or a blocked bile duct. Bilirubin metabolism begins with the breakdown of red blood 
cells. Red blood cells contain hemoglobin, which is broken down to heme and globin. 
Heme is converted to bilirubin, which is then carried by albumin in the blood to the liver. 
In the liver, most of the bilirubin is chemically attached to a glucuronide before it 
is excreted in the bile (National Institute of Health, 2005). This "conjugated" bilirubin is 
called direct bilirubin; unconjugated bilirubin is called indirect bilirubin. Total serum 
bilirubin equals direct bilirubin plus indirect bilirubin. 
Conjugated bilirubin is excreted into the bile by the liver and stored in the gall 
bladder or transferred directly to the small intestines (National Institute of Health, 2005). 
Bilirubin is further broken down by bacteria in the intestines to urobilins, which 
contribute to the color of the feces. A small percentage of these compounds are 
reabsorbed and eventually appear in the urine, where they are referred to as urobilinogen. 
The normal range for total bilirubin is 0.3 to 1.9 mgldl, direct bilirubin 0.0 to 0.3 
mg/dl, indirect bilirubin 0.0-0.1 mgldl (National Institute of Health, 2005). 
Total protein (TP) is a rough measure of all serum proteins. Protein measurements 
can reflect nutritional state, kidney disease, liver disease, and many other conditions 
(National Institute of Health, 2005). If total protein is abnormal, further tests must be 
performed to identify which protein fraction, and then which specific protein, is 
abnormal. 
Serum proteins are grossly separated into albumin and globulins (National 
Institute of Health, 2005). That is, total protein equals albumin plus globulin. Globulins 
are roughly divided into alpha-1, alpha-2, beta, and gamma globulins. Normal values 
may vary slightly from laboratory to laboratory but are typically range from 6.0 to 8.3 
gldl. 
Albumin levels can contribute in determining liver disease or kidney disease and 
if enough protein is being absorbed by the body (National Institute on Health, 2005). 
Albumin is the protein of highest concentration in plasma and transports many small 
molecules in the blood (for example, bilirubin, calcium, progesterone, and drugs). It is 
also of prime importance in maintaining the oncotic pressure of the blood (that is, 
keeping the fluid from leaking out into the tissues). 
Because albumin is synthesized by the liver, decreased serum albumin may result 
from liver disease (National Institute of Health, 2005). It can also result from kidney 
disease, which allows albumin to escape into the urine. Decreased albumin may also be 
explained by malnutrition or a low protein diet. Normal values may vary slightly from 
laboratory to laboratory but are typically range from 3.4 to 5.4 gldl (National Institute of 
Health, 2005). 
Dietary Modzfication 
Dietaryfiber. The definition of dietary fiber has always been controversial. 
However, one of the most widely accepted definitions states that "Fiber is composed of 
the plant polysaccharides and lignins which are resistant to digestion by the digestive 
enzymes of man" (Shils et al., 1999). It is a physiological rather than chemical response. 
Dietary fiber was originally called crude fiber, a term from ruminant nutrition that 
referred to the fraction of plant material that was resistant to ruminant digestion and 
therefore of no nutritional value (Shils et al., 1999). It constituted the very resistant 
cellulose lignin fraction of what is now called dietary fiber. The chief dietary fiber 
components of interest are the water-insoluble celluloses, hemicelluloses, and lignins, 
and the water-soluble pectice substances, gums, and mucilates. 
The health benefits of eating cereal and high fiber plant foods in general were 
promoted in the 1 9th century by the well-known health advocates Graham and Kellogg in 
America and Allision in Britain (Shils et al., 1999). However, much of the interest 
generated in the later half of this century is the results of the work of Denis Burkitt and 
Hugh Trowell. From their experiences of over 30 years of medical and surgical practice, 
and subsequent studies of disease incidence in other countries, they proposed that many 
Western diseases resulted from malabsorption to low fiber diets including colonic 
disorder, constipation, diverticular disease, colon cancer, and such systemic disorders as 
hyperlipidemia, cardiovascular disease, diabetes, and obesity. 
Since their original hypothesis, results of studies involving fiber have been 
controversial. Most studies have varying levels of fiber, minerals, protein, and other 
substances in the diet that are also important and contribute to the confusion when 
comparing different studies. Many times the type of fiber is also variable, and indications 
are that insoluble fibers are more likely than soluble fibers to have adverse effects (Shils 
et al., 1999). 
Though controversy surrounds much of the research, there is a clear body of 
evidence that supports fiber's effect on the body with such physiological effects as 
lowering plasma cholesterol levels, modifjring the glycemic response, improving large 
bowel function, and lowering nutrient availability which occurs in both isolated fiber 
fractions and in fiber-rich foods. 
According to Bowman and Russell (2001), many studies in humans and animals 
have shown that certain types of dietary fiber lower plasma cholesterol concentrations. 
These studies have been done with foods rich in dietary fiber, fractions from foods that 
are fiber enriched, and isolated polysaccharides. Many of these studies were conducted 
with relatively high intakes of fiber sources and meta-analysis indicates that a diet 
containing 2-10 grams of fiber per day is associated with cholesterol lowering effects. 
These studies note that reduction in total plasma cholesterol are in ranges from 5%-lo%, 
although decreases of up to 25% have been reported. Almost invariably, the reductions 
occur in LDL cholesterol fraction with little or no change in HDL cholesterol (Bowman 
& Russell, 200 1). 
It is unclear how dietary fiber lowers cholesterol. There are several hypotheses 
that have been put forth over the years. They involve increased steroid excretion as bile 
acids or cholesterol, decreased cholesterol synthesis, or increased removal of cholesterol 
from the plasma (Bowman & Russell, 2001). 
Fiber also plays an integral role in total diabetes care and management. In 
persons with type I1 diabetes mellitus, increasing fiber from 24 grams per day to 50 
grams per day has been reported to improve glycemic control, reduce hyperinsulinemia, 
and decrease plasma lipids (Chandalia et al., 2000). 
In 2001, Bowman and Russell reported associations between high-fiber diets and 
a lower incidence of certain chronic disorders, such as cardiovascular diseases and the 
improvement in glucose tolerance with fiber intakes, typically with the greatest reduction 
coming from the consumption of more then 20glday. Bowman and Russell (200 l), also 
reported that another important role of fiber in the prevention of these health concerns 
may lie in its impact on improving short-term, meal specific satiety. Though it is widely 
known that high levels of fiber are needed to maintain optimal health, the 
recommendations vary greatly from culture to culture (Bowman & Russell, 2001). 
Bread. Humans have eaten some form of bread since the Neolithic era, when 
cereal grains were crushed and mixed with water to form a thick paste that could be 
cooked over the fire and consumed (Essortment, 2002). The Egyptians, in approximately 
2600 BC were lucky enough to have a sufficient amount of wild yeasts in the air from 
brewing beer to accidentally discover its uses in leavening bread. Workers were often 
paid in loaves of bread. Paintings in the pyramids show that the dead were buried with 
loaves of bread, to provide sustenance in the afterlife. 
Greek sailors and merchants brought the Egyptian flour back to Greece, where 
bread baking flourished (Essortrnent, 2002). Rome took over the enterprise afier their 
conquest of Greece, and in 150 BC formed the first Baker's Guilds. Guilds were not only 
a way to garner professional respect, but a way to protect the public. The Baker's Guilds 
in England were held to strict standards, with harsh punishments for overcharging and/or 
adulterating the bread. 
During the early Middle Ages, much of the bread returned to unleavened loaves, 
although the Normans reintroduced leavened bread in 1 191 (Essortment, 2002). By the 
early 13th century, millers became more important--their job of turning wheat to flour not 
only allowed for more gradations of flour, but the practice of keeping up to a quarter of 
the flour produced made millers quite wealthy and thus of no little importance in their 
towns and villages. 
The lack of millers in the early days of colonial America, along with the lack of 
wheat, posed problems for the housewife (Essortment, 2002). How to make bread 
without the basic ingredients? The presence of corn quickly led to the invention of 
cornbread (alternately referred to johnny-cake or journey cake). Even after wheat became 
common, those in the Southern colonies had trouble making loaves of bread rise due to 
the high heat and humidity that killed off the necessary wild yeasts. Biscuits became the 
favored flour-based bread, while cornbread remained popular as well. The advent of 
roller flour mills in the 1800s led to even more highly processed flour--which led to 
lighter and whiter loaves, even if not as nutritious as the coarser whole wheat. 
Unfortunately, due to the increase in availability of highly processed flours and 
breads, consumption of whole grain breads has decreased (Whole Grains Council, 2005). 
This is unfortunate because whole grains or foods made from them contain all the 
essential parts and naturally-occurring nutrients of the entire grain seed. If the grain has 
been processed (e.g., cracked, crushed, rolled, extruded, lightly pearled, cooked, and/or 
bleached), the food product often does not deliver approximately the same rich balance of 
nutrients that are found in the original grain seed. 
There are two major differences between white bread and whole grain breads - 
how they are processed and how healthful they are. The flour for both is made from 
wheat berries, which have three nutrient-rich parts: the bran (the outer layers), the germ 
(the innermost area) and the endosperm (the starchy part in between). Whole wheat is 
processed to include all three nutritious parts, but white flour uses only the endosperm. 
Because of this, whole wheat is also much higher in fiber, vitamins [B.sub.6] and E, 
magnesium, zinc, folic acid and chromium. 
Recent epidemiologic investigations have found that whole grain intake is 
associated with reduced risk of various chronic diseases, especially cardiovascular 
diseases, diverticular disease, constipation and diabetes (Harvard School of Public 
Health, 2006). It has also been found that fasting insulin was 10% lower during 
consumption of the 6-10 serving whole-grain diet including whole wheat breads than 
during consumption of the refined-grain diet and breads (mean difference: - 15 +I- 5.5 
pmol/L; P = 0.03; Pereira et al., 2002). 
According to the indications of a study published in 2002 with nearly 3000 
participants, whole grains and whole grain breads that were high in fiber were shown to 
have a significant inverse relationships with BMI, total cholesterol, LDL, and fasting 
insulin levels (Lairon, Arnault, Bertrais, Planells, Clero, Hercberg & Boutron-Ruault, 
2005). 
A recent study of nearly 40,000 women using a semi-quantitative food frequency 
questionnaire was published in 2002. This study also indicted that women who 
consumed the greatest number of fiber rich whole grains including breads had inverse 
relationships with relative risk factors associated with cardiovascular disease (Lui, 
Buring, Sesso, Rimrn, Willett, & Manson, 2002). 
Chapter 111: Methodology 
The purpose of this study was to determine the effects of increasing the 
consumption of breads containing high fiber on an overweight population's diet, to 
evaluate if the health risks associated with heart disease would decrease, determine if 
increased fiber consumption affected liver function or if participants' food frequency 
consumption of unhealthy foods would change. Included in this chapter are subject 
selection and description, recruitment procedures, instrumentation and data collection 
procedures and analysis. 
Subject Selection and Description 
Participants of this study were 18 years of age or older. The participants were 
volunteers solicited by advertisement in the Dunn County Newpaper and through the 
UW-Stout faculty email. Upon response, participants were informed of dates and times 
available for their evaluations. 
During the initial evaluation participants were given a consent letter (Appendix 
A) indicating testing procedures, confidentiality, potential risks, and benefits of the 
research. Additional questions regarding the testing were also answered at this time. 
Assurance that the participants' participation was voluntary was stated through 
email, on the consent form, and during each of the three testing procedures. All questions 
about their participation were answered honestly and completely by the examiner through 
email, on the telephone, and in person. 
Upon initially submitting the food frequency questionnaire and consent form, 
participants were weighed using a TanitaTM TBF-410GS bioelectrical impedance scale. 
This non-invasive device calculated the participants' weight, BMI, and body 
composition. Participants who did not accurately follow the guidelines for the test 
emailed to them (Appendix B) with the consent letter (Appendix A) and those whose 
BMI was under 25 were informed they did not fit the desired qualifications for the 
experiment. 
Participants were randomly assigned to either a control group receiving only 
information on the benefits of a high fiber diet (Appendix D) or an experimental group 
receiving information on the benefits of a high fiber diet (Appendix D) and breads high 
in fiber. The experimental group members were instructed to gradually increase their 
consumption from three slices of bread per day for the first two weeks up to six slices of 
bread per day for the final two weeks by increasing their consumption one slice per day 
every two weeks over the course of the eight week study. Participants receiving the 
bread were assigned bimonthly dates and times available for pickup of their bread. If 
their schedules did not allow, alternate arrangements were made available. At four and 
eight weeks both the control and experimental groups were asked to return with a 
completed food frequency questionnaire and for follow-up testing of their body weight, 
body composition, blood glucose, BMI, lipid profile, and liver enzyme function. 
Instrumentation 
The instruments employed in this study were a food frequency questionnaire 
(Appendix C) used to obtain the participants eating habits and a TanitaTM bioelectrical 
impedance scale to obtain the participants body weight, BMI, and body composition. 
Blood samples of the participants were taken and analyzed at Red Cedar Medical Center 
in Menomonie, Wisconsin to determine blood glucose, lipid profile, and enzyme 
functions. 
John Hopkins foodfiequency questionnaire (Appendix C). A food frequency 
questionnaire is a retrospective review of intake frequency - that is food consumed per 
day, per week, and per month. For ease of evaluation the food frequency chart organizes 
foods into groups that have common nutrients. Because the focus of the food frequency 
questionnaire is the frequency of consumption of food groups rather than of specific 
nutrients, the information obtained is general, not specific, for certain nutrients (Mahan & 
Escott-Stump, 2004). 
TanitaTM TBF-4 10GS bioelectrical impedance scale. Age group, gender and 
height were entered into the scale prior to the participant stepping onto the platform. 
Electrodes in the foot sensor pads sent a low, safe signal through the body. Weight was 
calculated automatically along with body fat content and BMI in less than a minute. 
TanitaTM Bioelectrical Impedance Analysis (BIA) is considered the world leader in 
electronic scales (Tanita, 2004). BIA measures the impedance or resistance to the signal 
as it travels through the water that is found in muscle and fat. The more muscle a person 
has, the more water their body can hold. The greater the amount of water in a person's 
body, the easier it is for the current to pass through it. The higher the fat composition, the 
more resistance to the current. BIA is safe and is not painful. The signal used in body fat 
monitors can not be detected or felt by the participant. 
Blood withdrawalprocedures. Laboratory testing was conducted before week one 
and after weeks four and eight with an approximate time of 15 minutes required per 
testing session. A professional laboratory technician withdrew all blood samples using 
the following procedures: 
Cleaned port with alcohol swab. 
Connected the blood sampling needle to the blood collection sleeve. 
o The blade end was inserted into the sleeve. 
Connected slip-lock end into the blood sampling port of the stopcock. 
Inserted discard blood tube into the blood collection sleeve until the blade 
"grabbed" the top of the tube. 
Turned the stopcock off towards the flush system. 
Pushed the vacuum tube into the sleeve. 
o Obtained at least 3 mL discard. 
o Disposed of discard sample in sharps container. 
Turned stopcock to 45' between each tube change. Turned stopcock before 
removing the sample tube. 
Collected remaining samples - used the minimum amount of blood required to 
obtain sample. 
When a sample was being drawn: 
o Ensured that a total volume of 5 mL or more has been obtained prior to 
drawing. 
o Obtained blood gas sample AFTER drawing. 
o Ensured stopcock was not turned to 90°between tube changes. 
After the last sample was drawn, turned stopcock "off' to patient catheter. 
Covered sampling port with several gauze squares. 
Tilted sampling port downward. 
Pulled flush device, back flushing into gauze until port was completely free of 
blood. 
Turned stopcock to sampling port. 
If any blood remained in port, it was cleaned with an alcohol swab. 
Replaced cap. 
Flushed catheter until all evidence of blood was cleared. 
Data Collection 
In February, 2005, permission to conduct this study was obtained through the 
University of Wisconsin-Stout Institutional Review Board. The participants were 21 
volunteers solicited by advertisement in the Dunn County Newpaper and through the 
UW-Stout faculty email. Upon response, participants were informed of dates and times 
available for their evaluations. 
Upon completing the consent form participants were weighed using a TanitaTM 
bioelectrical impedance scale. Participants who did not accurately follow the guidelines 
for the procedure emailed to them with the consent letter (Appendix A) and those whose 
BMI was < 25 were informed they did not fit the desired qualifications for the 
experiment. Confidentiality was maintained by rotating participants through the 
assessment lab using portable privacy curtains. 
Participants were randomly assigned to either a control group receiving 
information on the benefits of a high fiber diet or into an experimental group receiving 
information on the benefits of a high fiber diet and breads high in fiber containing ground 
flaxseed. The experimental group members were instructed to gradually increase their 
consumption from three slices of bread per day for the first two weeks up to six slices of 
bread per day for the final two weeks by increasing their consumption one slice per day 
every two weeks over the course of the eight week study. Participants receiving the 
bread were assigned bimonthly dates and times available for pickup of their bread. If 
participants' schedules did not allow alternate arrangements were made available. At 
four and eight weeks both the control group and experimental groups were asked to 
return with a completed food frequency questionnaire (Appendix C) and for follow-up 
testing of their body weight, body composition, blood glucose, BMI, lipid profile, and 
liver enzyme function. 
Data Analysis 
All body weight, body composition, and BMIs were recorded upon measurement 
on the TanitaTM scale. All blood glucose, lipid profile, and liver enzyme function tests 
were analyzed at Red Cedar Medical Center, Menomonie, Wisconsin. The Food 
Frequency Questionnaire (Appendix C) was used to analyze the consumption of food 
groups and general nutrient intakes. 
The one-, four-, and eight weeks body weight, body composition, BMI, blood 
glucose, lipid profile, liver enzyme function tests and food frequency data were entered 
into SPSS (Statictical Package for the Social Science) statistical software to interpet and 
seperate all data. Means and standard deviations for participant weight, body 
composition, BMI, lipid profile, liver panel, and food frequency were calculated. 
Chapter IV: Results 
This primary purpose of study was to evaluate the effects of increasing the 
consumption of high fiber breads on an overweight population's diet and assessing if 
health risks associated with heart disease would decrease due to the increased 
consumption. A secondary purpose was to evaluate if participants' food frequency 
consumption or liver function would change due to the increased fiber and whole grain 
consumption. 
Initially, approximately 75 inquiries were received by potential participants. 
After screening individuals to insure appropriate BMI > 25 there were 39 participants, 
however, after each was emailed with details of the study, a consent form (Appendix A) 
and a date for initial testing only approximately 30 attended the initial scheduled testing. 
During the initial briefing of the details and review of the consent form one participant no 
longer wished to participate in the study. Six more did not return for the week four 
follow up testing. One participant was removed from the study due to lack of continued 
bread consumption recommendations. Since only one male completed the study, his data 
was removed to make the finding solely applicable to females. 
There were a total of 21 female participants who completed the study with nine in 
the control group and 12 in the experimental group. At the I-, 4-, and 8-week timeframes 
body weight, body composition, BMI, blood glucose, lipid profile, liver enzyme function 
tests and food frequency data were gathered and entered into SPSS statistical software to 
determined data means and standard deviations. Two way analysis of variance with 
repeated measures on week 1, week 4, and week 8, using "CON EXPO" were 
determined. There was no significant differences found within each group or between 
groups in any comparison using a significance factor of 0.5. 
Anthropometric Data 
A BMI of 18.5 - 24.9 for adults represents a healthy target body weight. A BMI 
from 25.0 - 29.9 classifies individuals as overweight and a BMI over 30 classifies 
individuals as obese (Center for Disease Control, 2004a). Table 1 indicates the mean 
starting and ending BMI for both the control and experimental groups exceeded 29.5 in 
all measured values. As shown in Table 1 there was an insufficient decrease, and in 
some cases an increase in both the mean weight, BMI and body fat percentages of the 
control and experimental groups after no consumption and consumption of high fiber 
breads. There were no significant differences found within each group or between groups 
in any comparison using a significance factor of 0.5. 
Fasting Blood Glucose 
"Normal" fasting blood glucose is considered a value of < 100 mgldl (College of 
American Pathologists, 2005). Table 2 indicates the mean fasting blood glucose of the 
control group decreased from 94.38mgldl during week 1 testing to 78.5mgldl during 
week 8 testing. The mean fasting blood glucose of the experimental group decreased 
2.44 mgldl from 87.92-85.48 mgldl during week 8 testing. There were no significant 
differences found for fasting blood glucose within each group or between groups in any 




A desirable lipoprotein value of cholesterol level is less than 200 mg/dl. 
Triglyceride levels are classified as normal ( 4  50 mg/dl), borderline high (1 50-199 
mg/dl), high (200 - 499 mg/dl) and very high (>500 mg/dl) (Mahan and Escott-Stump, 
2000). A desirable LDL level is less then 130 mg/dl. Desirable HDL cholesterol is 
greater than 40 mg/dl. Because women have higher HDL cholesterol than men, and HDL 
cholesterol level of greater then 45 mg/dl is recommended in women. 
Table 3 indicates the four lipid tests that were evaluated over the course of the 
eight week study. It shows the mean week one cholesterol of the experimental group at 
213.25 mg/dl with a 7.42 mg/dl decrease in mean cholesterol to 205.83 mgldl during 
week eight. The week one triglyceride level of the experimental group was 133.5 mg/dl 
with an 1 1.92 mgldl decrease in mean triglycerides to 121.58 mg/dl during week eight. 
The mean HDL of the experimental group was 49.58 mg/dl with a mean increase of 1.34 
mg/dl to 50.92 mg/dl during week eight. The mean LDL level of the experimental group 
was 135 mg/dl during week one with a mean decrease of 3.17 mg/dl to 12 1.83 mg/dl 
during week eight. 
Table 3 also indicates the week one mean cholesterol of the control group as 
201.88mg/dl with a mean decrease of 23.13 mg/dl to 178.75 mg/dl during week eight 
testing. The week one mean triglyceride levels of the control group was 170.13 mgldl 
with a 41.38mgJdl decrease in mean triglycerides to 121.58 mg/dl during week eight. 
The mean LDL of the control group was 50.38 mg/dl with a 2.5 mg/dl decrease in mean 
HDL to 47.88 mg/dl during week eight. The mean LDL of the control group was 114.13 
mgldl during week one with a 13.1 7 mgldl point decrease in mean LDL to 10 1.63 mgldl 
during week eight. 
There were no significant differences found in lipids within each group or 
between groups in any comparison using a significance factor of 0.5. 
Liver Enzymes 
Liver enzyme function analysis was conducted solely at the request of the 
research sponsor to determine if increased consumption of high fiber bread had a 
detrimental impact on liver function. 
Normal alanine aminotransferase (ALT) values range from 7-56 IUIL, normal 
alkaline phosphatase (ALKP) values range from 20 to 140 IUL, normal aspartate 
aminotransferase (AST) levels range fiom 10 to 34 IUIL, the normal range for total 
bilirubin (TBIL) is 0.3 to 1.9 mgldl, direct bilirubin (DBIL) ranges from 0.0 to 0.3 mgldl, 
indirect bilirubin (UCBIL) ranges from 0.0-0.1 mgldl, total protein typically ranges from 
6.0 to 8.3 gldl and normal albumin ranges from 3.4 to 5.4 gldl (NIH, 2005). 
Table 4 shows the results of the liver enzyme tests. It indicates that the 
experimental group's mean total protein increased by 0.06 g d d l ,  mean albumin 
increased by 0.01 gldl, mean AST decreased by 1.05 IUIL, mean ALT increased by 2.12 
IUIL, mean ALKP increased by 2.83 IUIL, mean TBIL decreased by 0.2 mgldl, mean 
UCBIL decreased by 0.125 mgldl, mean CBIL decreased by 0.083 mgldl, and mean 
direct BIL decreased by 0.008 mgldl over the eight week study period. 
Table 4 also shows that the control group's mean total protein increased by 
0.12gdd1, mean albumin decreased by 0.03gId1, mean AST increased by 2.75IU/L, mean 
ALT decreased by O.l3IU/L, mean ALKP decreased by 0.13IU/L, mean TBIL decreased 
by 0.075mgId1, mean UCBIL decreased by O.O5mg/dl, and that their was no change in 
CBIL or direct BIL over the eight week study period. There were no significant 
differences found in liver enzymes within each group or between groups in any 
comparison using a significance factor of 0.5. 
Table 3 
Adjusted Mean (M) and Standard Deviation (SD) Results for Lipid Profile of Control and Experimental Groups 
Week 1 Week 4 Week 8 
Control EXP Control EXP Control EXP 
Cholesterol (mgldl) 201.88 * 37.16 213.25 42.63 183.5 41.24 202.17 36.39 178.75 39.61 205.83 39.53 
Triglycerides (mgldl) 170.13 130.73 133.5 34.83 125.63 60.30 124.50 * 44.47 128.75 41.50 121.58 * 58.32 
HDL (mgldl) 50.38 * 13.09 49.58 * 12.15 52.50 * 12.06 52.50 9.52 47.88 16.64 50.92 10.3 1 
LDL (mgldl) 114.13 28.53 135.00 * 35.29 105.88 * 35.94 124.67 32.97 101.63 * 33.24 121.83 49.42 
Note. Control N = 9; Experimental N = 12; HDL= High density lipoproteins; LDL= Low density lipoproteins. 
4 0 
Table 4 
Adjusted Mean (M) and Standard Deviation (SD) Results for Liver Enzymes of Control and Experimental Groups 
Week 1 Week 4 Week 8 
Control EXP Control EXP Control EXP 
Total Protein 7.14 h 0.26 7.36 * 0.36 7.39 * 0.19 7.36 h 0.30 7.26 h 0.45 7.42 h 0.32 
(mg/dl) 
Albumin 4.16 * 0.16 4.17 * 0.32 4.35 * 0.20 4.23 0.26 4.13 h 0.34 4.18 h 0.26 
(mg/dl) 
AST (IUIL) 28.25 * 15.80 33.00 h 16.42 27.75 * 12.60 31.75 * 25.48 31.00 h 21.76 31.50 h 14.61 
ALT (IU/L) 35.88 * 23.80 37.08 h 23.96 37.25 * 20.30 36.92 h 34.72 33.75 h 33.36 33.75 * 22.00 
ALKP (IU/L) 79.63 * 22.50 83.25 * 34.17 79.75 * 25.10 83.75 39.41 79.50 h 25.35 86.08 * 36.20 
TBIL (mgldl) 0.49 * 0.10 0.78 h 0.20 0.49 * 0.10 0.69 * 0.19 0.41 0.10 0.58 * 0.24 
CBIL (mgldl) 0.00 * 0.00 0.00 * 0.00 0.00 * 0.00 0.00 0.00 0.00 0.00 0.08 * 0.29 
DBIL (mgldl) 0.00 0.00 0.01 h 0.03 0.00 * 0.00 0.09 * 0.03 0.00 * 0.00 0.00 * 0.00 
Note. Control N_ = 9; Experimental N_ = 12; AST= asparatate aminotransferase; ALT= alanine aminotransferase; ALKP= alkaline 
phosphatase; TBIL= total bilirubin; UCBIL= indirect bilirubinl; CBIL= conjugated bilirubin; DBIL= direct bilirubin 
Food Frequency Questionnaire 
Codes were assigned to each consumption frequency category. A code number 
"1" was assigned to foods consumed one time or less per month. A code number "2" was 
assigned to foods consumed two to three times per month. A code number "3" was 
assigned to foods consumed one to two times per week. A code number "4" was 
assigned to foods consumed three to four times per week. A code number "5" was 
assigned to foods that were consumed five or more times per week. Data was analyzed 
with a two-way analysis of variance with repeated measures on the original values 
assigned to each person's answers. 
Combination Foods 
All measures are expressed as frequency of consumption determined by two-way 
analysis with repeated measures. Table 5 shows the difference in consumption of 
combination foods among the experimental and control groups. Neither group had any 
significant changes in the foods listed on the food frequency questionnaire at a 
significance factor of 0.05. There was also less than a 0.6 category consumption increase 
or decrease in any of the items eaten by either group. 
Proteins 
All measures are expressed as frequency of consumption determined by two-way 
analysis with repeated measures. Table 6 shows the difference in consumption of protein 
foods among the experimental and control groups. Neither group had any significant 
changes in the foods listed at a significance factor of 0.05. There was also less than a 
one unit consumption increase or decrease in any of the items eaten by either group. 
Fats, Oils and Sweets 
All measures are expressed as frequency of consumption determined by two-way 
analysis with repeated measures. Table 7 indicates insufficient change in the 
consumption of foods catagorized as fats, oils and sweets. Neither group had any 
significant changes in the foods listed at a significance factor of 0.05. Only butter or oils 
used in cooking and butter or margarine on bread had a mean that decreased more than 
one unit over the eight week period in the control group with only the mean chocolate 
consumption decreased by more than one category over the eight week period in the 
experimental group. 
Table 5 
Adjusted Mean (M) and Standard Deviation (SD) Results for Combination Food Consumption of Control and Experimental Groups 
Week 1 Week 4 Week 8 
Control EXP Control EXP Control EXP 
Pizza 2.00 * 0.93 2.08 * 0.52 2.00 * 1.31 1.75 * 0.45 1.88 * 0.99 2.00 * 0.74 
French Fries, Hash Browns 1.63 * 0.92 1.27 * 0.47 1.75 * 0.89 1.46 * 0.69 1.75 * 0.89 1.818 * 0.87 
Frozen Food Entree 1.38 * 0.52 1.634 * 1.03 1.25 * 0.46 1.46 * 0.93 1.38 * 0.74 2.00 * 1.62 
Lasagna, Chili 1.25 * 0.46 1.64 * 0.51 1.25 * 0.46 1.55 * 0.52 1.38 * 0.52 1.455 * 0.52 
Chinese Food 1.13 * 0.35 1.73 * 0.65 1.38 * 0.52 1.91 * 0.81 1.38 * 0.52 2.00 * 0.52 
Note. Control N = 9; Experimental N=12; Measures expressed as frequency of consumption determined by two-way analysis 
with repeated measures. Items means reflect the following response choices: 1= Month or less; 2= 2-3lmonth; 3= 1 -2lper week; 4= 3- 
4lper week; 5= 5 or morelper week. 





























